{
  "chunk_id": "V_iii_3_None_10",
  "content": "/>\nV.iii.3.1.e\n.\nEvaluations Under the Infectious Diseases General Rating Formula\nPrior to the August 11, 2019, rating schedule revision, each infectious disease listed under\n38 CFR 4.88b\nhad its own prescribed rating criteria.\nEffective August 11, 2019,\n38 CFR 4.88b\ncontains a general rating formula applicable to multiple infectious diseases, regardless of etiology.\nFor each diagnostic code (DC) that refers to this general rating formula, decision makers must\nassign the prescribed evaluation during the active disease phase, and thereafter,\nassign\na 0-percent evaluation for the infectious disease under the relevant\n38 CFR 4.88b\nDC, and\nevaluations for any residual disability of the infection within the appropriate body system as indicated by the notes in the evaluation criteria.\nNotes\n:\nRegardless of whether resolution occurs spontaneously or because of treatment, long-term disability in such situations results from residual functional impairment of the body systems affected by the infectious disease, rather than the infection itself.\nInfectious diseases for both the initial diagnosis and any relapse of active infection must be confirmed by diagnostic testing specific to the disease.",
  "title": "M21-1, Part V, Subpart iii, Chapter 3 - Infectious Diseases, Immune Disorders, and Nutritional Deficiencies",
  "citation": "Part V, Subpart iii, Chapter 3, Section None",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014467/M21-1-Part-V-Subpart-iii-Chapter-3-Infectious-Diseases-Immune-Disorders-and-Nutritional-Deficiencies",
  "updated": "",
  "scraped_at": "2025-06-16T22:44:20.990940",
  "tags": [
    "m21-1"
  ]
}